1H MRS studies in the Finnish boron neutron capture therapy project: Detection of 10B-carrier, L-p-boronophenylalanine-fructose

European Journal of Radiology

Volumn 56, Issue 2, 2005, Pages 154-159

  Timonen, M ^a   Kankaanranta, L ^b,c   Lundbom, N ^a   Collan, J ^b,c   Kangasmaki A ^b   Kortesniemi, M ^a,c   Hakkinen A M ^b   Lonngren A ^c   Karjalainen, S ^c   Rasilainen, M ^b   Leinonen, J ^b   Huitti, T ^b   Jaaskelainen J ^d   Kouri, M ^b,c   Savolainen, S ^a,c   Heikkinen, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Boneca Corporation   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Blood; Blood plasma; BNCT; BPA F; MRS

Indexed keywords

BLOOD; FRUCTOSE; NEUTRONS; PLANNING; PLASMAS; PROJECT MANAGEMENT; SPECTROSCOPIC ANALYSIS; TUMORS;

BLOOD PLASMA; BORON NEUTRON CAPTURE THERAPY (BNCT); L-P-BORONOPHENYLALANINE-FRUCTOSE (BPA-F); MRS;

BORON;

4 BORONOPHENYLALANINE; 4 BORONOPHENYLALANINE FRUCTOSE B 10; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG; 4 BORONOPHENYLALANINE FRUCTOSE; 4-BORONOPHENYLALANINE-FRUCTOSE; BORON; BORON DERIVATIVE; DRUG DERIVATIVE; FRUCTOSE; HYDROGEN; ISOTOPE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; FEMALE; GLIOBLASTOMA; HUMAN; LABORATORY TEST; MALE; NEUTRON CAPTURE THERAPY; NOSE CARCINOMA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY; TUMOR VOLUME; BRAIN TUMOR; CARCINOMA; FINLAND; IMAGE QUALITY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARANASAL SINUS TUMOR; PATHOLOGY; PLASMA; TUMOR RECURRENCE;

ADULT; AGED; BORON; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; CARCINOMA; FEMALE; FINLAND; FRUCTOSE; GLIOBLASTOMA; HUMANS; HYDROGEN; ISOTOPES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM RECURRENCE, LOCAL; PARANASAL SINUS NEOPLASMS; PHANTOMS, IMAGING; PLASMA; RADIOPHARMACEUTICALS;

EID: 26944469961     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2005.03.017     Document Type: Article

References (30)

1. A.Z. Diaz, J.A. Coderre, A.D. Chanana, and R. Ma Boron neutron capture therapy for malignant gliomas Ann Med 32 2000 81 85
2. 10B-p-boronophenylalanine in tumours, skin and blood of melanoma patients: a study of boron neutron capture therapy for malignant melanoma Melanoma Res 9 1999 75 83
3. R. Nano, S. Barni, and P. Chiari Efficacy of boron neutron capture therapy on liver metastases of colon adenocarcinoma: optical and ultrastructural study in the rat Oncol Rep 11 2004 149 153
4. Pinelli T, Zonta, Altieri S, et al. TAOrMINA: from the first idea to the application on the human liver. In: Sauerwein W, Moss R, Wittig A, editors. Research and development in neutron capture therapy (Se 8-13, 2002, Essen, Germany). Bologna: Moduzzi Editore; 2002. p. 1065-72.
5. M. Kouri, L. Kankaanranta, and T. Seppala Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy Radiother Oncol 72 2004 83 85
6. Seppälä T. FiR 1 epithermal neutron beam model and dose calculation for treatment planning in neutron capture therapy, Ph.D. thesis. Helsinki, Finland: University of Helsinki; 2002 (http://ethesis.helsinki.fi/ julkaisut/mat/fysik/vk/seppala/).
7. H. Joensuu, L. Kankaanranta, and T. Seppälä Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronophenylalanine J Neuro-Oncol 62 2003 123 134
8. 13C NMR evidence for the β-d-fructofuranose 2,3,6-(p-phenylalanyl-orthoborate) structure J Pharm Sci 89 2000 215 222
9. J. Laakso, M. Kulvik, and I. Ruokonen Atomic emission method for total boron in blood during neutron-capture therapy Clin Chem 47 2001 1796 7803
10. Kortesniemi M. Solutions for clinical implementation of boron neutron capture therapy in Finland, Ph.D. thesis. Helsinki, Finland: University of Helsinki; 2002 (http://ethesis.helsinki.fi/julkaisut/mat/fysik/vk/kortesniemi/).
11. M. Kortesniemi, T. Seppälä, I. Auterinen, and S. Savolainen Enhanced blood boron concentration estimation for BPA-F mediated BNCT Appl Radiat Isot 61 2004 823 827
12. 10B concentration after BPA-fructose complex infusion in patients during epithermal neutron irradiation in BNCT Int J Radiat Oncol Biol Phys 48 2000 1145 1154
13. 10B in boron neutron capture therapy, Ph.D. thesis. Helsinki, Finland: University of Helsinki; 2002 (http://ethesis.helsinki.fi/julkaisut/mat/fysik/vk/ryynanen/).
14. C.S. Zuo, P.V. Prasad, P. Busse, L. Tang, and R.G. Zamenhof Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture Med Phys 26 1999 1230 1236
15. 10B-carrier, BPA-F using STEAM and PRESS MRS sequences: detection limit and quantification Spectrosc Int J 18 2004 133 142
16. 10B-carrier, BPA-F: phantom studies at 1.5 and 3.0 T Phys Med Biol 48 2003 1027 1039
17. Gordon RE, Ordidge RJ. Volume selection for high-resolution NMR studies. In: Proceedings of the third annual meeting of the society of magnetic resonance in medicine, Book of abstracts. Berkeley, CA: SMRM; 1984. p. 272.
18. P.A. Bottomley Spatial localization in NMR spectroscopy in vivo Ann N Y Acad Sci 508 1987 333 348
19. 1H proton NMR chemical shift selective (CHESS) imaging Phys Med Biol 30 1985 341 344
20. 18F-fluoro-l-phenylalanine-fructose as a probe for boron neutron capture therapy in glioma-bearing rat model J Nucl Med 45 2004 302 308
21. E.H. Elowitz, R.M. Bergland, J. Coderre, D.D. Joel, M. Chadha, and A.D. Chanana Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy Neurosurgery 42 1998 463 469
22. J.A. Coderre, A.D. Chanana, and D.D. Joel Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity Radiat Res 149 1998 163 170
23. T.L. Nichols, G.W. Kabalka, L.F. Miller, M.K. Khan, and G.T. Smith Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography Med Phys 29 2002 2351 2358
24. G.W. Kabalka, T.L. Nichols, G.T. Smith, L.F. Miller, M.K. Khan, and P.M. Busse The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma J Neuro-Oncol 62 2003 187 195
25. P.M. Munck af Rosenschold, W.F. Verbakel, C.P. Ceberg, F. Stecher-Rasmussen, and B.R. Persson Toward clinical application of prompt gamma spectroscopy for in vivo monitoring of boron uptake in boron neutron capture therapy Med Phys 28 2001 787 795
26. 10B MRI Magn Reson Med 46 2001 13 17
27. 10B NMR Med Phys 28 2001 178 183
28. P. Bendel, A. Frantz, J. Zilberstein, G.W. Kabalka, and Y. Salomon Boron-11 NMR of borocaptate: relaxation and in vivo detection in melanoma-bearing mice Magn Reson Med 39 1998 439 447
29. G.W. Kabalka, C. Tang, and P. Bendel The role of boron MRI in boron neutron capture therapy J Neuro-Oncol 33 1997 153 161
30. 10B double resonance Magn Reson Med 32 1994 170 174